Market Tracker

01/16 5:15pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.47
Delayed Data
As of 4:00pm ET
 -0.115 / -4.45%
Today’s Change
2.00
Today|||52-Week Range
7.15
+2.92%
Year-to-Date

Today’s Trading

Previous close2.59
Today’s open2.61
Day’s range2.40 - 2.68
Volume201,916
Average volume (3 months)136,394
Market cap$29.8M
Data as of 4:00pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)+22.05%
Earnings growth (this year)+25.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)-19.90%
P/E ratioNM
Price/Sales0.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc+0.21+3.01%
CDMOPAvid Bioservices Inc+0.05+0.21%
TCONTRACON Pharmaceutica...+0.10+3.45%
AMPEAmpio Pharmaceutical...+0.08+2.73%
Data as of 4:10pm ET, 01/16/2018

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$3.90
Annual revenue (last year)$140.9M
Annual profit (last year)-$169.6M
Net profit margin-120.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
Secretary, Chief Legal &
Compliance Officer, SVP
Kenneth R. PiƱa
Corporate headquarters
Morristown, New Jersey

Forecasts